Conditions

EULAR 2014: Biosimilar Drug Production Raises Concerns

Rheumatology experts question biosimilars’ safety, efficacy given their complex production process

Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA

Kathy Holliman | August 1, 2014

Researchers found patients with morbid obesity, gout and diabetes achieved target serum urate concentrations post-bariatric surgery

Richard Quinn | August 1, 2014

Patient access to rheumatologists a serious concern in rural and underserved U.S. communities

From the College | August 1, 2014

Level 4 coding for a follow-up visit by a patient with gout

From the College | August 1, 2014

Medical decision-making for established diagnosis of gout that is worsening

James T. Rosenbaum, MD | August 1, 2014

A rheumatologist voices skepticism that physicians, patients can arrive at mutually shared healthcare decisions

Rheumatologists can gain insight into patients’ state of health by watching them walk

Nancy Sharby, PT, DPT, MS | August 1, 2014

Why screening for depressive symptoms in patients with arthritis is needed

Mell Gutarra-Arana, MD; Theniat Haider, MD; Theodore Kieffer, MD; & Steven Hugenberg, MD | August 1, 2014

Diagnosis, treatment and management of AMF in Hispanic patient with lupus